Fortis Therapeutics Raises $18M

San Diego-based Fortis Therapeutics, a new biotech company in the immuno-oncology area, announced this morning that it has raised $18M in a Series A funding. The funding was led by Avalon Ventures and also included Bregua Corporation, Lilly Asia Ventures, Osage University Partners, and Vivo Capital. The startup, based in the COI Pharmaceuticals cluster of companies in San Diego, is based on research developed by Bin Liu, Ph.D., a professor in the Department of Anesthesia at UC San Francisco. Fortis Therapeutics said it is developing drug therapies for late-stage metastatic castrate-resistant prostate cancer and multiple myeloma. More information »